13 Parents
| Identifier | Name | Description |
|---|---|---|
| DOID:4 | disease | A disease is a disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism. |
| DOID:0014667 | disease of metabolism | A disease that involving errors in metabolic processes of building or degradation of molecules. |
| DOID:0050177 | monogenic disease | A genetic disease that is the result of one or more abnormal alleles and may be dominant, semi-dominant, or recessive. |
| DOID:630 | genetic disease | A disease that has_material_basis_in genetic variations in the human genome. |
| DOID:0050739 | autosomal genetic disease | A monogenic disease that has_material_basis_in a mutation in a single gene on one of the non-sex chromosomes. |
| DOID:0050737 | autosomal recessive disease | An autosomal genetic disease that is characterized by the presence of two mutated copies of the gene, both of which must be present in order for the disease or trait to develop. |
| DOID:3211 | lysosomal storage disease | An inherited metabolic disorder that involve an abnormal accumulation of substances inside the lysosome resulting from defects in lysosomal function. |
| DOID:655 | inherited metabolic disorder | A disease of metabolism that is characterized by enzyme deficiency or accumulation of enzymes or toxins which interfere with normal function due to inherited enzyme abnormality. |
| DOID:1927 | sphingolipidosis | A lipid storage disease characterized by functional deficiencies in the enzymes needed for lysosomal degradation of sphingolipid substrates. |
| DOID:9455 | lipid storage disease | A lysosomal storage disease that involves the accumulation of harmful amounts of lipids (fats) in some of the body's cells and tissues. |
| DOID:2368 | gangliosidosis | A sphingolipidosis that is characterized by the accumulation of lipids known as gangliosides. |
| DOID:3321 | GM2 gangliosidosis | A gangliosidosis that is characterized by excessive accumulation of ganglioside GM2 and related glycolipids in the lysosomes. |
| DOID:3320 | Tay-Sachs disease | A GM2 gangliosidosis that is characterized onset in infancy of developmental retardation, followed by paralysis, dementia and blindness, with death in the second or third year of life and has_material_basis_in homozygous or compound heterozygous mutation in the alpha subunit of the hexosaminidase A gene (HEXA) on chromosome 15q23. |
12 Relations
| Relationship |
Parent Term . Identifier |
Child Term . Identifier |
|---|---|---|
| is_a | DOID:3321 | DOID:3320 |
| is_a | DOID:655 | DOID:3320 |
| is_a | DOID:9455 | DOID:3320 |
| is_a | DOID:0050177 | DOID:3320 |
| is_a | DOID:4 | DOID:3320 |
| is_a | DOID:0014667 | DOID:3320 |
| is_a | DOID:630 | DOID:3320 |
| is_a | DOID:3211 | DOID:3320 |
| is_a | DOID:0050739 | DOID:3320 |
| is_a | DOID:2368 | DOID:3320 |
| is_a | DOID:0050737 | DOID:3320 |
| is_a | DOID:1927 | DOID:3320 |
